NCT04358510 is a clinical trial of COViage in COVID-19, sponsored by Dascena.

Who is sponsoring NCT04358510?

NCT04358510 is sponsored by Dascena.

What drugs are being tested in NCT04358510?

Interventions in NCT04358510: COViage.

What condition does NCT04358510 study?

NCT04358510 studies COVID-19, Pneumonia, Mechanical Ventilation.

Is NCT04358510 still recruiting?

NCT04358510 is currently completed. Last updated 24 April 2020.

Last reviewed 2020-04-24 · How we verify

NCT04358510

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

COVID-19 Mortality Prediction Model

Completed Last updated 24 April 2020

What this trial tests

trial testing COViage in COVID-19 in 114 participants. Completed in 17 April 2020.

Timeline

1 April 2020

Primary endpoint
17 April 2020

17 April 2020

Quick facts

Lead sponsor	Dascena
Status	Completed
Study type	OBSERVATIONAL
Enrollment	114
Start date	1 April 2020
Primary completion	17 April 2020
Estimated completion	17 April 2020
Sites	1 location across United States

Drugs / interventions tested

COViage

Conditions studied

COVID-19 — all drugs for COVID-19 →
Pneumonia — all drugs for Pneumonia →
Mechanical Ventilation — all drugs for Mechanical Ventilation →

Sponsor

Dascena

Who can join

18 and older, any sex, with COVID-19 or Pneumonia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to develop and evaluate an algorithm which accurately predicts mortality in COVID-19, pneumonia and mechanically ventilated ICU patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Mortality prediction model for the triage of COVID-19, pneumonia, and mechanically ventilated ICU patients: A retrospective study.
Ryan L, Lam C, Mataraso S, Allen A, et al · · 2020 · cited 40× · PMID 33042536 · DOI 10.1016/j.amsu.2020.09.044

Verify or expand the search:

Other trials of COViage

Trials testing the same drug.

NCT04390516 — Respiratory Decompensation and Model for the Triage of COVID-19 Patients · NA · completed
NCT04423991 — Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning · NA · completed

Other recruiting trials for COVID-19

Currently open trials in the same condition.

NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting

Other Dascena trials

Trials by the same sponsor.

NCT03734484 — Gram Type Infection-Specific Sepsis Identification Using Machine Learning · Phase 2 · withdrawn
NCT03752489 — Unsupervised Machine Learning for Clustering of Septic Patients to Determine Optimal Treatment · Phase 2 · unknown
NCT04005001 — Machine Learning Sepsis Alert Notification Using Clinical Data · Phase 2 · unknown
NCT04358536 — Classification of COVID-19 Infection in Posteroanterior Chest X-rays · completed
NCT04390516 — Respiratory Decompensation and Model for the Triage of COVID-19 Patients · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04358510 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dascena
Last refreshed: 24 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04358510.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing